DAVID LAM, Wachtell

Deal in Brief: AbbVie Spin-off
Deal Value: $54 billion
Firm’s Role: Advised on spin-off
Deal Trivia: Number of existing contracts Wachtell reviewed in connection with the spin-off: over 21,600